Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2025-12-25 @ 2:30 AM
NCT ID:
NCT06050434
Eligibility Criteria:
Inclusion Criteria:
* Enrolled participant of the GISAR registry and their sub-studies
* Patient with histologically confirmed soft tissue sarcomas
* Pretreatment with Trabectedin, termination of this therapy regardless of reason
* Planned rechallenge or started rechallenge with Trabectedin in any line of therapy within 2 weeks before inclusion
* Interval between last Trabectedin treatment and Trabectedin rechallenge at least 3 months
Exclusion Criteria:
* Not able to understand all implications of study participation
* No written informed consent
* Age ≤ 18 years
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06050434
Study Brief:
Protocol Section:
NCT06050434